Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
Philip Morris International (NYSE: PM) has announced an 8.9% increase in its regular quarterly dividend to an annualized rate of $5.88 per share. The new quarterly dividend of $1.47 per share will be payable on October 20, 2025, to shareholders of record as of October 3, 2025.
PMI has maintained a consistent track record of dividend increases since its public listing in 2008, achieving a total increase of 219.6% with a compound annual growth rate of 7.1%. The company's smoke-free products are now available in 97 markets, reaching over 41 million consumers, and accounting for 41% of PMI's first-half 2025 total net revenues.
The company has invested over $14 billion in developing smoke-free products since 2008, with FDA authorizations for its IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches.
Philip Morris International (NYSE: PM) has released its 2025 Sustainability Materiality Report, outlining its sustainability strategy through 2030 and beyond. The report, following double materiality principles, identifies six strategic priorities organized into a new Sustainability Framework focusing on both product and operational impacts.
The Framework addresses product impact through social consumer initiatives and environmental circularity, while operational impact covers workforce development, value chain ethics, climate action, and nature protection. PMI's smoke-free products are now available in 97 markets, used by 41 million consumers, and account for 41% of first-half 2025 total net revenues. The company has invested over $14 billion since 2008 in developing and commercializing smoke-free alternatives.
Philip Morris International (NYSE: PM) reaffirmed its 2025 full-year forecast during the Barclays Global Consumer Staples Conference. The company expects reported diluted EPS of $7.24 to $7.37 and adjusted diluted EPS of $7.43 to $7.56, representing growth of 13% to 15% (11.5% to 13.5% excluding currency).
PMI reported strong Q3-to-date performance, highlighting accelerated ZYN growth to 32% in the first 8 weeks of Q3, robust IQOS momentum, and better-than-expected combustible volume recovery in Turkey and Egypt. The company's smoke-free products are now available in 97 markets, used by over 41 million consumers, and accounted for 41% of first-half 2025 total net revenues.
Since 2008, PMI has invested over $14 billion in smoke-free product development, aiming to completely end cigarette sales and expand into wellness and healthcare areas.
Philip Morris International (NYSE: PM) announced it will host a fireside chat session at the 2025 Barclays Global Consumer Staples Conference. CEO Jacek Olczak will lead the session on September 2, 2025, at 11:15 a.m. ET, with a live webcast available at pmi.com/2025barclays.
The company provided key business updates, highlighting that its smoke-free products are now available in 97 markets with approximately 41 million users globally. The smoke-free segment contributed 41% of PMI's first-half 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing and commercializing smoke-free products, demonstrating its commitment to a smoke-free future.
Philip Morris International (NYSE: PM) reported strong Q2 2025 results, with reported diluted EPS growing 26.6% to $1.95 and adjusted diluted EPS increasing 20.1% to $1.91. The company's smoke-free business now accounts for 41% of total net revenues, up 2.9 percentage points year-over-year.
Key highlights include IQOS exceeding $3 billion in quarterly net revenues, ZYN's U.S. offtake growth reaccelerating to 36% in June, and smoke-free product shipment volumes increasing by 11.8%. The company raised its full-year 2025 guidance, now projecting adjusted diluted EPS of $7.43-$7.56, representing 13-15% growth.
Total net revenues reached $10.1 billion, up 7.1% year-over-year, while operating income grew 7.8% to $3.7 billion. The company's smoke-free products are now available in 97 markets, with IQOS maintaining approximately 76% global heat-not-burn category share.
Philip Morris International (NYSE: PM) has announced it will host a live audio webcast to discuss its 2025 second-quarter and first-half results on Tuesday, July 22, 2025, at 9:00 a.m. ET. The results will be released at approximately 7:00 a.m. ET the same day.
The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products, with FDA authorizations for IQOS devices, General snus, and ZYN nicotine pouches.
Philip Morris International (NYSE: PM) has announced it will host a live webcast of its presentation at the 2025 dbAccess Global Consumer Conference. The session will feature CFO Emmanuel Babeau on June 3, 2025, at 11:15 a.m. CET. The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing smoke-free products, demonstrating its commitment to a smoke-free future. The company has received FDA authorizations for its IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches.